Non-Drowsy Sudafed Decongestant (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride, the active ingredient in Non-Drowsy Sudafed Decongestant, is an imidazoline nasal decongestant presented as a nasal spray for topical nasal use. It relieves nasal congestion associated with the common cold, sinusitis, and allergic rhinitis in adults and children.

GNH USA supplies Non-Drowsy Sudafed Decongestant as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams worldwide.

Xylometazoline Hydrochloride is indicated for nasal congestion arising from several common upper‑respiratory conditions.

- Common cold: reduces nasal blockage and improves airflow. - Sinusitis: alleviates mucosal swelling to ease sinus drainage. - Allergic rhinitis: diminishes congestion caused by allergen‑induced inflammation.

Xylometazoline Hydrochloride may cause local or systemic adverse reactions, most of which are mild and transient.

Common Side Effects: - Nasal irritation: mild burning or stinging. - Sneezing: transient increase in sneezing. - Dryness of nasal mucosa: feeling of dryness or crusting. - Headache: mild headache. - Bitter taste: unpleasant taste after use.

Serious or Rare Side Effects: - Nasal septum perforation: rare tissue damage with prolonged use. - Hypertension: elevated blood pressure in susceptible individuals. - Severe allergic reaction: rash, swelling, or anaphylaxis.

When using Xylometazoline Hydrochloride, consider the following precautions.

- Duration of use: limit to no more than 3‑5 days to avoid rebound congestion. - Age restrictions: avoid in children under 2 years unless directed by a healthcare professional. - Cardiovascular conditions: use with caution in patients with hypertension or heart disease. - Concurrent nasal medications: do not combine with other vasoconstrictive nasal sprays without medical advice. - Pregnancy and lactation: consult a physician before use as safety data are limited. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and direct sunlight.

Xylometazoline Hydrochloride can interact with other medicines; review the following categories.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase risk of hypertensive events. - Other nasal decongestants: additive vasoconstriction can cause severe hypertension. - Sympathomimetic drugs: combined effect may raise blood pressure.

Moderate Interactions (Monitor Closely): - Antihypertensive medications: monitor blood pressure as the decongestant may reduce efficacy. - Beta‑blockers: possible attenuation of decongestant’s systemic effects. - Tricyclic antidepressants: may enhance sympathomimetic activity.